Investor

Columbus Venture Partners

columbusvp.com ↗ ·Valencia ·Multi stage ·Actively investing

Spanish independent venture capital firm focused exclusively on life sciences and biotechnology, investing in therapeutic and industrial biotech platforms from seed through growth stages. Headquartered in Valencia with offices in Madrid, Barcelona and Boston, it has raised multiple funds (including a ~€220M Fund V) and counts 11+ exits such as AskBio, Aura Biosciences and Sanifit Therapeutics among its track record.

Portfolio

Team

AUM

~€600M

Rounds

Cheque

€2–15M

SectorsBiotechnology, Life Sciences, Therapeutics, Healthcare/Medtech VC MapSeries B

Profile updated 17 Jul 2026

Team

Partners 8 Investment Team 3 Others 7

Damià Tormo

General Partner (Co-Founder)

Javier García

General Partner (Co-Founder)

Jose Mesa

Partner

José Vicente Pons

Operating Partner

—

Julen Oyarzabal

Partner & CSO

Marc Marco

Partner

—

Marisol Quintero

Operating Partner

Robert Armstrong

Partner

Portfolio companies 19

Advanthera

advanthera.com

Company Other Tres Cantos

Algenex

algenex.com

Company Other Tres Cantos

ARTHEx Biotech

arthexbiotech.com

Company Series B Valencia

Cocoon Bioscience

cocoonbio.com

Company Series A Bilbao

Curapath

curapath.com

Company Other Valencia

deepull

deepull.com

Company Series C Barcelona

Highlight Therapeutics

www.highlighttherapeutics.com

Company Series D Valencia

Integra Therapeutics

integra-tx.com

Company Other Barcelona

Minoryx Therapeutics

minoryx.com

Company Series C Mataró

Multiverse Computing

multiversecomputing.com

Company Series B San Sebastián

Ona Therapeutics

ona-therapeutics.com

Company Series B Barcelona

Quatre Lab

quatrelab.com

Company Seed San Sebastián

Company Series D Palma de Mallorca

Company Series B Zamudio

TAAV Biomanufacturing Solutions

taav.com

Company Other San Sebastián

Tyris Tx

tyristx.com

Company Other Valencia

Viralgen

viralgen.com

Company Other San Sebastián

Funding rounds 13

Ona Therapeutics · Series B · €74.2M

IRB Barcelona spin-out closed an oversubscribed €74.2M Series B co-led by Columbus and Mérieux to take its first-in-class antibody-drug conj…

2026-06-04

ARTHEx Biotech · Series B · $87M

ARTHEx Biotech announced it had upsized its Series B to $87M total with new investor Bpifrance (via its Large Venture and InnoBio funds) lea…

2025-09-17

Highlight Therapeutics · Series B · €15M

Valencia-based Highlight Therapeutics closed a €15M round led by Buenavista Equity Partners through its BV Healthcare Growth Innvierte I fun…

2025-09-16

Integra Therapeutics · Seed · €10.7M

Integra Therapeutics, a Pompeu Fabra University spin-off developing the FiCAT gene-writing platform, closed a €10.7 million pre-Series A rou…

2025-09-08

deepull · Series C · €50M

Barcelona-based medtech deepull closed an oversubscribed €50 million Series C co-led by Columbus Venture Partners, Panakès Partners and Méri…

2025-04-29

Multiverse Computing · Series A · €25M

Multiverse Computing closed an oversubscribed €25 million (about $27.1M) Series A to scale its Singularity quantum/quantum-inspired optimisa…

2024-03-05

Cocoon Bioscience · Series A · €2M

Cocoon Bioscience, which uses cocooned insects as bioreactors to produce enzymes and growth factors for pharma and cultivated meat, raised €…

2023-11-06

ARTHEx Biotech · Series B · €42M

Valencia-based clinical-stage biotech ARTHEx closed a €42M Series B led by Columbus Venture Partners to take ATX-01, an antimiR targeting mi…

2023-05-03

Cocoon Bioscience · Series A · €15M

Cocoon Bioscience, an Algenex spin-out that uses cocooned insects as natural bioreactors to make specialty enzymes and growth factors for mR…

2023-03-14

Minoryx Therapeutics · Series C · €51M

Barcelona-area orphan-drug developer Minoryx closed a €51M Series C co-led by Columbus Venture Partners and Caixa Capital Risc (no single le…

2022-05-31

Integra Therapeutics · Seed · €1.5M

Integra Therapeutics, a Universitat Pompeu Fabra spin-off developing the FiCAT gene-writing platform, closed a new €1.5 million investment l…

2022-03-29

Highlight Therapeutics · Other · €22.6M

Highlight Therapeutics, formerly Bioncotech, is a clinical-stage biotech. It closed €22.6M co-led by Columbus Venture Partners' Life Science…

2021-02-03

Algenex · Series B · €7.4M

Algenex is a biotech company with production facilities in Tres Cantos. It raised a €7.4M private round led by MasterLux (advised by Cleon C…

2020-09-08

News & media 10

Published	Article
2026-06-19	Columbus Venture Partners closes its largest biotechnology and life sciences fund, sized at up to €220 million ↗ Capital-Riesgo.es
2026-06-04	Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development ↗ GlobeNewswire
2026-05-27	AI firm Visium secures funds to scale across Europe and US ↗ startupticker.ch
2026-03-04	ABE Capital Partners and Columbus Venture Partners acquire a majority stake in Sermes CRO to accelerate its growth ↗ Sermes CRO (press release)
2026-01-06	Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology ↗ BusinessWire
2025-11-06	Accipiter Biosciences Emerges from Stealth with $12.7 Million in Seed Financing to Deliver de novo Protein Therapies for Complex Diseases ↗ GlobeNewswire
2025-09-17	Columbus Venture Partners launches the Columbus Life Sciences Fund V with a target of €200 million ↗ Capital-Riesgo.es
2025-09-17	ARTHEx Biotech Upsizes Series B Financing Round to $87M to Advance Lead Program ATX-01 in Myotonic Dystrophy Type 1 and Expand Pipeline of Targeted RNA Medicines ↗ PRNewswire
2025-09-08	Integra Therapeutics raises €10.7M to advance FiCAT platform and CAR-T validation ↗ Tech.eu
2024-06-10	Syngoi Technologies Expands Synthetic DNA Manufacturing Capacity Following Series B Investment Led by Columbus Venture Partners ↗ Syngoi (press release)